164 related articles for article (PubMed ID: 34830108)
1. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma.
Tseng YK; Chen CF; Shu CW; Lee CH; Chou YT; Li YJ; Liou HH; Cheng JT; Chen CL; Ger LP; Liu PF
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830108
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.
Fan T; Chen Y; He Z; Wang Q; Yang X; Ren Z; Zhang S
Toxicol Lett; 2019 Oct; 314():142-152. PubMed ID: 31319114
[TBL] [Abstract][Full Text] [Related]
4. [Effect of up-regulation of Decorin on expression of EGFR, C-Myc and p21 in nude mice with oral squamous cell carcinoma].
Guo MY; Li KY; Nie MH; Liu XQ
Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):40-46. PubMed ID: 36973842
[TBL] [Abstract][Full Text] [Related]
5. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
Wang M; Feng Z; Li X; Sun S; Lu L
Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
[TBL] [Abstract][Full Text] [Related]
6. Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma.
Wang WM; Yang SS; Shao SH; Nie HQ; Zhang J; Su T
Front Endocrinol (Lausanne); 2022; 13():828608. PubMed ID: 35222283
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of RAB27A in Oral Squamous Cell Carcinoma Promotes Tumor Migration and Invasion via Modulation of EGFR Membrane Stability.
Huang J; Yang JG; Ren JG; Xia HF; Chen GH; Fu QY; Zhang LZ; Liu HM; Wang KM; Xie QH; Chen G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685910
[TBL] [Abstract][Full Text] [Related]
8. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
9. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
[TBL] [Abstract][Full Text] [Related]
10. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
12. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
13. Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
Miranda Galvis M; Santos-Silva AR; Freitas Jardim J; Paiva Fonseca F; Lopes MA; de Almeida OP; Lópes Pinto CA; Kaminagakura E; Sawazaki-Calone I; Speight PM; Kowalski LP
J Oral Pathol Med; 2018 Jan; 47(1):32-39. PubMed ID: 28626969
[TBL] [Abstract][Full Text] [Related]
14. NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy.
Fan T; Wang X; Zhang S; Deng P; Jiang Y; Liang Y; Jie S; Wang Q; Li C; Tian G; Zhang Z; Ren Z; Li B; Chen Y; He Z; Luo Y; Chen M; Wu H; Yu Z; Pi H; Zhou Z; Zhang Z
Signal Transduct Target Ther; 2022 Apr; 7(1):130. PubMed ID: 35462576
[TBL] [Abstract][Full Text] [Related]
15. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
[TBL] [Abstract][Full Text] [Related]
16. EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex.
Lei Y; Kansy BA; Li J; Cong L; Liu Y; Trivedi S; Wen H; Ting JP; Ouyang H; Ferris RL
Oncogene; 2016 Sep; 35(36):4698-707. PubMed ID: 26876213
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
Yang Y; Chen D; Liu H; Yang K
Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
[TBL] [Abstract][Full Text] [Related]
18. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
19. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
[TBL] [Abstract][Full Text] [Related]
20. miR‑144‑3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2.
He L; Liao L; Du L
Int J Mol Med; 2020 Aug; 46(2):828-838. PubMed ID: 32626925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
